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A comprehensive understanding of the cellular
functions of the Hsp90 molecular chaperone
has remained elusive. Although Hsp90 is essen-
tial, highly abundant under normal conditions,
and further induced by environmental stress,
only a limited number of Hsp90 ‘‘clients’’ have
been identified. To define Hsp90 function, a
panel of genome-wide chemical-genetic screens
in Saccharomyces cerevisiae were combined
with bioinformatic analyses. This approach
identified several unanticipated functions of
Hsp90 under normal conditions and in response
to stress. Under normal growth conditions,
Hsp90 plays a major role in various aspects of
the secretory pathway and cellular transport;
during environmental stress, Hsp90 is required
for the cell cycle, meiosis, and cytokinesis. Im-
portantly, biochemical and cell biological analy-
ses validated several of these Hsp90-depen-
dent functions, highlighting the potential of our
integrated global approach to uncover chaper-
one functions in the cell.
INTRODUCTION
Protein folding and assembly in the cell often requires the
assistance of a diverse set of enzymes known as molecu-
lar chaperones. The major chaperone systems in the
eukaryotic cytosol, Hsp70, TRiC/CCT, and Hsp90, are
each essential for viability, suggesting that they fulfill non-
overlapping functions (Frydman, 2001; Young et al., 2004).
Despite intensive mechanistic and functional studies, the
spectrum of cellular substrates and functions mediated
by these different chaperones remains largely undefined.
A better characterization of the division of labor amongdifferent chaperone systems is key to understanding the
underlying logic of cellular protein folding. The recent
identification of Hsp90 as a promising target for antican-
cer therapies also highlights the practical implications of
understanding the extent of chaperone function in the
cell (Whitesell and Lindquist, 2005).
Hsp90 is the central component of a complex chaper-
one system whose cellular functions and mechanism are
still poorly understood (Pearl and Prodromou, 2006;
Young et al., 2004). In higher eukaryotes, Hsp90 collabo-
rates with a large set of cochaperones tomediate the con-
formational regulation of tyrosine kinases and steroid hor-
mone receptors (reviewed in Buchner, 1999; Picard, 2006;
Young et al., 2001). Hsp90 has also been proposed to
buffer phenotypic variation of these signaling molecules,
allowing cells to maintain a wild-type phenotype in the
face of genetic mutations (Sangster et al., 2004). The
structures of Hsp90 and several Hsp90 cofactors have re-
cently been elucidated (Pearl and Prodromou, 2006), but it
is still unclear how this chaperone recognizes its sub-
strates or affects their conformation.
Biochemical and genetic approaches suggest that
Hsp90 is not a general chaperone for newly synthesized
proteins. An important open question is whether the cellu-
lar function of Hsp90 is restricted to the conformational
regulation of the limited set of substrates or ‘‘clients’’ iden-
tified to date. Considering that Hsp90 constitutes 1%–
2% of cytosolic proteins and is essential for viability in
yeast, which lack tyrosine kinases and steroid hormone
receptors, it is likely that Hsp90 performs as yet unidenti-
fied cellular functions. Additionally, the precise contribu-
tion of Hsp90 in protecting cells from stress remains
undefined (Nathan et al., 1997). Thus, while Hsp90 levels
are highly induced by environmental stress, it is required
neither to confer thermotolerance nor to prevent the
aggregation of heat-inactivated proteins (Nathan et al.,
1997). Traditional biochemical and genetic approaches
to define chaperone substrates in vivo have been hindered
by many factors, including the low affinity of mostCell 131, 121–135, October 5, 2007 ª2007 Elsevier Inc. 121
Figure 1. Experimental Scheme and Graphical Representation of Homozygous Deletion Pool Data
(A) Pooled homozygous diploid deletion strains comprisingmost nonessential ORFs were grown in the absence (no drug added) or presence (HSP90-
inhibiting drug added) of Macbecin II. A deletion strain hypersensitive to the loss of Hsp90 function (depicted in red) will grow less robustly than
unaffected strains upon drug addition. Upon subsequent hybridization of PCR-amplified molecular barcodes to complementary high-density oligo-
nucleotide arrays, decreased signal intensity correlates with decreased presence of that particular strain in the pool. The resulting Ratio values (Rv)
describe how the growth of each deletion strain was affected by HSP90 inhibition.
(B) Each deletion strain (deleted ORF) was plotted versus the averaged Rv from five independent 30C experiments. The top 5% most growth-
inhibited strains were selected as the data set for further study (average Rv% 0.86; 192 ORFs).
(C) Each deletion strain (deletedORF) was plotted versus the averaged ratio values (Rvs) from three independent 37Cexperiments. Again, the top 5%
constitutes the data set for further study (average Rv% 0.65; 208 ORFs).chaperone-substrate interactions and the pleiotropic and
essential nature of chaperone action. The emergence of
globalmethods of analysismay provide an avenue to over-
come some of these problems. However, these methods
also present significant shortcomings, most notably the
limited confidence level of many of the measurements
and the difficulties of extracting coherent and significant
conclusions from such large amounts of data. A few geno-
mic studies have explored the function of Hsp90 using
TAP pulldowns, two-hybrid interaction, synthetic genetic
arrays (SGA), and chemical-genetic screening of a haploid
yeast deletion collection (Millson et al., 2005; Zhao et al.,
2005). These screens yielded several potential Hsp90 in-
teractors: two new ‘‘client’’ proteins, the kinases Hog1p
and Slt2p, and two new cochaperones, Tah1p and Pih1p,
both containing the known Hsp90-interacting TPR do-
main. While each of these different global approaches122 Cell 131, 121–135, October 5, 2007 ª2007 Elsevier Inc.identified potential Hsp90 interactors, they did not pro-
duce an integrated picture of the cellular functions of
Hsp90. The limited overlap between potential targets pro-
duced by the different approaches further underscores
the limitations of genome-wide screens.
To define the cellular functions of Hsp90, we combined
genomic screens that produce quantitative high-confi-
dence datawith in-depth bioinformatic analyses (Figure 1).
This strategy produced novel and unexpected insights
into Hsp90-dependent cellular processes both under nor-
mal growth conditions and during environmental stress.
We find that, under normal growth conditions, Hsp90 facil-
itates protein secretion and trafficking. In addition, during
environmental stress, Hsp90 is required for progression of
the cell cycle, meiosis, and cytokinesis. Importantly, bio-
chemical and cell biological approaches validate some
of the Hsp90-dependent functions revealed in our screen.
Given the potential of Hsp90 as an anticancer target, a bet-
ter understanding of Hsp90 functions may facilitate the
design of better therapeutic strategies. Further, the effi-
cacy of this combined approach in uncovering Hsp90
function may lay the groundwork for a comprehensive
analysis of chaperone function in vivo.
RESULTS
Experimental Approach: Genome-wide Screen
for Hsp90 Function
A chemical-genetic screen using diploid yeast collections
containing precise deletions of each open reading frame
(ORF) (Winzeler et al., 1999) and a pharmacological inhib-
itor of Hsp90 (Bohen, 1998) was used to generate a quan-
titative measure of deletion strains whose growth is nega-
tively affected when Hsp90 function is compromised
at either 30C or 37C (Figure 1). Each deletion strain is
marked by kanamycin resistance and flanked with a
unique ‘‘molecular barcode.’’ A pool containing all ho-
mozygous deletion strains was grown in the presence of
an Hsp90-inhibiting drug and quantitatively analyzed by
hybridization of the identifier barcodes to a high-density
oligonucleotide array (Giaever, 2003). Screening the ho-
mozygous diploid deletion pool offers significant advan-
tages over similar approaches using the haploid deletion
collection strains. For example, haploid strains in the dele-
tion collection are known to harbor secondary mutations
unlinked to the kanamycin integration cassette (Deutsch-
bauer et al., 2005). The use of the diploid collection genet-
ically masks such recessive background mutations. Given
its proposed role in buffering genetic variation, this con-
sideration is particularly relevant for Hsp90, as growth de-
fects in haploid cells upon Hsp90 inactivation may also
arise from secondarymutations. Importantly, the yeast cy-
tosolic Hsp90 proteins are the only targets of theHsp90 in-
hibitors used in this study, as S. cerevisiae lacks the endo-
plasmic reticulum (ER) Hsp90-homolog Grp94.
We initially determined the effective concentration(s) of
Hsp90-inhibiting drug macbecin II (herein MII) using
a yeast strain deleted for STI1/HOP (Hsp Organizing Pro-
tein), a known cochaperone of Hsp90. We employed MII
instead of the related andmore widely used geldanamycin
becauseMII is more effective in vivo in yeast cells while re-
taining specificity for Hsp90 (Bohen, 1998). We reasoned
that deletion of the known Hsp90 cochaperone STI1,
combined with inhibition of Hsp90 function, would result
in decreased fitness of sti1D cells grown in solution. In-
deed, while the growth of WT yeast was similarly affected
by either 200 mM or 400 mM MII, sti1D yeast exhibited
a dose-dependent decrease in growth rate (Figure S1A
in the Supplemental Data available with this article online).
These experiments therefore established an MII concen-
tration range that selectively uncovers gene deletions
that are hypersensitive to Hsp90 impairment, without pro-
ducing unwanted cytotoxic effects on strains that are less
dependent on Hsp90 function.We next grew pooled homozygous diploid deletion
strains, representing the majority of all nonessential
ORFs, in the absence and presence of MII (Figure 1A).
To gain insight into Hsp90 function under normal and
stress conditions, experiments were carried out at both
30C (i.e., normal) and 37C (i.e., thermal stress) growth
temperatures. The pooled strains were grown for five gen-
erations, then diluted into fresh media and grown for an
additional five generations (Figure S1B). Genomic DNA
prepared from cells collected after ten generations of
growth was hybridized on arrays containing unique mo-
lecular barcodes identifying each deletion strain. Impor-
tantly, the relative strength of the signals obtained with
and without drug for each deletion strain was used to de-
rive a Ratio value, or Rv, which provides a quantitative
measure of the effect of Hsp90 impairment on the growth
rate of each strain (see Figure 1A and Experimental Proce-
dures). This Rv served as a marker of the impact of the ex-
perimental condition on the fitness of each deletion strain
(Giaever et al., 2002). Thus, an Rv <1 indicates a growth
defect when Hsp90 is inhibited (Figure 1A and Experimen-
tal Procedures). As a critical control, we confirmed for sev-
eral individual deletion strains identified in our screen that
the deletion rendered them susceptible to chemical inhibi-
tion of Hsp90 outside of the context of being grown in
a pool (Figures S1 and S2).
The global impact of inhibiting Hsp90 was next as-
sessed by plotting the Rv value (Figure 1A) of each deleted
ORF in the pool (Figures 1B and 1C) to generate a picture
of the overall fitness of strains in the pool (Table S1). Most
deletion strains had an Rv equal to or greater than 1, indi-
cating that they were not hypersensitive to Hsp90 inhibi-
tion (Figures 1B and 1C). Of the small fraction of strains
negatively affected by Hsp90 inhibition (Rv < 1), we se-
lected the top 5% most sensitive deletion strains for fur-
ther analysis. The resulting 30C data set consists of 192
genes, all with an Rv %0.86. Analysis of the 37C data
set yielded 208 genes, all with an Rv%0.65. Notably, while
90 genes were present in both data sets, there were signif-
icant differences between the Hsp90-dependent strains
identified at either temperature (Figure 2A).
Bioinformatic Analyses of Hsp90 Target Data Sets
Enrichment of Known Hsp90 Interactors
Yeast contains two Hsp90 proteins, one encoded by the
stress-inducible HSP82 locus and one by the constitu-
tively expressed HSC82 locus. While both the 30C and
37C data sets contain the hsp82D/hsp82D deletion
strain, hsc82D/hsc82D yeast did not exhibit decreased fit-
ness in the presence of MII. It thus appears that, even
though Hsc82 and Hsp82 are nearly identical proteins
(95% identity, 99% conservation) and are expressed at
comparable levels in either the presence or absence of
MII (data not shown), they are not functionally equivalent
in vivo.
Next, we compiled a list of known Hsp90 interactors
(Hsp90 interactome; Table S2) from data available in
the BioGRID database (see Experimental Procedures).Cell 131, 121–135, October 5, 2007 ª2007 Elsevier Inc. 123
Figure 2. Overall Properties of the 30C
and 37C Hsp90 Targets in the Homozy-
gous Deletion Collection
(A) Degree of overlap between the data sets
from 30C and 37C experiments.
(B) GO Slim compartment, function, and pro-
cess categories were similarly significantly en-
riched in both the 30C (blue bars) and 37C
(red bars) top 5% data sets. Selection criteria
were (1) a valueR0.7 and%1.3 upon dividing
30C enrichment by 37C enrichment and (2)
more than one ORF assigned to at least one
of the two top 5% data sets.
(C) GO Slim compartment, function, and pro-
cess categories that exhibit a distinct enrich-
ment change comparing the 30C (blue bars)
and 37C (red bars) top 5% data sets selected
as in (B), but for values <0.7 or >1.3.Both the 30C and 37C data sets were significantly
enriched in Hsp90 interactome members (Table 1). For
instance, several high-confidence nonessential Hsp90 in-
teractors, such as HSP82 itself and the cochaperones
STI1, CPR6, and SBA1, were 1.9 times more likely to be
found in our screens than other Hsp90 targets, and 4.5
times more likely to be found in our screens than a ran-
dom protein. Importantly, given that our study essentially
represents a synthetic genetic analysis using a small-
molecule inhibitor to perturb Hsp90 function, the ob-
served enrichment for genetically established interactors124 Cell 131, 121–135, October 5, 2007 ª2007 Elsevier Inc.indicates that our data sets likely comprise bona fide
cellular targets of Hsp90.
Identification of Cellular Activities Enriched
among Hsp90 Targets
We next determined whether our data sets were enriched
in genes involved in specific cellular activities using avail-
able classifications from the Gene Ontology (GO) data-
base (Harris et al., 2004). To this end, the proportion of
genes in the MII-sensitive data sets assigned to a specific
GO classification was compared with the proportion of all
nonessential genes with the same assignation (Tables S3
Table 1. Hsp90 Data Sets Are Significantly Enriched for Known Hsp90 Interactors
Growth
Temperature
ORFs
Analyzed
Known Hsp90
Targets Analyzed
Known Hsp90
Targets in Top 5% Enrichment Ratioa Significance (p Value)
Genetic All Genetic All Genetic All Genetic All
30C 3792 178 415 39 55 4.3 2.6 1 3 1012 4 3 1012
37C 4121 204 458 41 56 4.0 2.4 1 3 1012 6 3 1011
a Enrichment ratio calculated as ([known Hsp90 interactors in top 5%]/[all top 5% ORFs])/([known Hsp90 interactors analyzed]/[all
analyzed ORFs]).and S4). This analysis revealed that some cellular func-
tions were indeed significantly enriched amongHsp90 tar-
gets. For the most significantly enriched GO classifica-
tions, at least 80% of the genes assigned to each
particular GO classification were identified in our 30C ex-
perimental data set (Table S3, for 30C p % 0.0002, fold
enrichmentR 15.8). GO Slim analysis for compartments,
functions, and processes enriched in both the 30C and
37C data sets revealed categories including transcription
factors, kinases, and mitochondrial membrane compo-
nents (Figure 2B). These target classes are in good agree-
ment with previously established Hsp90-dependent
‘‘clients’’ and functions (Picard, 2002; Pratt and Toft,
2003; Wegele et al., 2004). The correspondence between
GO analysis and known Hsp90 functions indicates that
GO categories may be useful to uncover novel cellular
functions of Hsp90.
We next analyzed GO Slim categorizations differentially
enriched at either 30C or 37C degrees. The Hsp90 30C
data set was significantly enriched in transport-related
categories, including vesicle-mediated transport and
Golgi apparatus (Figure 2C, blue bars; see also Table
S5). For instance, the 25 most sensitive strains in the
30C screen included 14 transport-related genes, includ-
ing multiple VPS genes and all four lobe B components of
the bilobular conserved oligomeric Golgi (COG) complex
(Ungar et al., 2002; Table S1). The striking enrichment of
components of the secretory pathway in our 30C data
set is also evident in Table S4 (p% 0.002; fold enrichment
R 3), suggesting that, under normal growth conditions,
Hsp90 plays an important role in protein trafficking.
To obtain insight into the function of Hsp90 during
stress, we next focused on GO Slim analysis of the 37C
data set, which, strikingly, identified a different set of
Hsp90-dependent processes (Figure 2C and Table S5).
For instance, while components of the microtubule orga-
nizing center were not enriched in the 30C data set,
they were dramatically enriched at 37C (4.5-fold enrich-
ment over genome frequency; Figure 2C, red bars). Simi-
larly, signal transduction, cell cycle, cytokinesis, and bud
components, while enriched in the 30C data set, were
more abundantly represented at 37C. The 37C data
set was also more enriched over the 30C data set in
some metabolism-related categories as well as, under-
standably, response to stress (Figure 2C, red bars).
Thus, at elevated temperatures Hsp90 appears to playan important role in the continued function of the cell cycle
machinery aswell as in themaintenance of certain types of
enzymatic activities.
Role of Hsp90 in Complex Assembly
Molecular chaperones can also facilitate assembly of olig-
omeric complexes (Frydman, 2001; Young et al., 2004). To
determine whether Hsp90 plays a role in complex forma-
tion, we assessed the enrichment of complex-forming
proteins in the 30C and 37C data sets (see Experimental
Procedures). Notably, there was a significant enrichment
in genes encoding subunits of oligomeric complexes
among ORFs unique to the 30C data set; 50% of
Hsp90 targets encoded subunits of oligomeric com-
plexes, compared to 30.4% of all ORFS analyzed at
30C. For instance, Hsp90 targets include genes coding
for subunits of the oligomeric complexes COG, AP-adap-
tor, and ESCRT, all of which function in the secretory path-
way (see also Table S7 and Figure 6B). Notably, this
enrichment was not observed in the 37C data set; only
36.4% of ORFs unique to the 37C data set are found in
complexes, compared to 32.4% of all ORFs analyzed at
37C. Thus, Hsp90 may function to stabilize or facilitate
formation of oligomeric complexes at 30C; this function
appears to be less relevant during thermal stress.
Enrichment of Structural Domains
among Hsp90 Interactors
Bioinformatic analysis using Pfam classifications to deter-
mine whether certain structural domains are enriched in
our experimental data sets yielded less defined trends.
However, several Pfam classes were enriched over back-
ground (p value % 0.034; Table S6). These included
several designations, including TPR domain-containing
proteins andDnaJ-type proteins that are known to interact
with Hsp90; thus, other categories enriched in our data
sets, such as the small GTPase domain found in Ras,
Rabs, and Arfs (see below) may also be relevant as either
substrate- or cochaperone-interacting motifs.
Network Analysis of Hsp90 Interactions
We next constructed an Hsp90 interaction network by
combining our data sets with curated physical and genetic
interactions from the BioGRID database (Stark et al.,
2006) (Figure 3A; see Experimental Procedures). Hsp90
targets present in the 30C, 37C, or both data sets
were grouped according to their shortest distance to
Hsp90. Loner nodes (107 ORFs out of the 310 total uniqueCell 131, 121–135, October 5, 2007 ª2007 Elsevier Inc. 125
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ORFs in our data sets) are not considered here, but these
as yet ‘‘unconnected’’ Hsp90 targets may represent an
unmined area of potential novel Hsp90 interactors.
Graph-theoretic analysis of Hsp90 targets in relation to
the yeast interaction network revealed that the average
shortest distance between Hsp90 targets is smaller than
expected from random chance (see Experimental Proce-
dures; Figure S3A). Accordingly, the number of gene pairs
that directly interact or were next-to-nearest neighbors
were much larger than expected for both the 30C and
37C data sets. For instance, the 30C data set contained
306 gene pairs with one step distance between them, i.e.,
connected by one edge, while the expected number was
23.9 (p value < 0.001); in addition, we observed 4629
gene pairs that are two steps/edges in distance but ex-
pected only 869.5 (p value < 0.001; Figure S3A). The ob-
servation that the genes identified in our screen are clus-
tered in the yeast interaction network indicates that
Hsp90 targets tend to interact with each other.
The nonrandom nature of our experimental Hsp90 inter-
action network was further underscored when the yeast
interaction network was integrated with our experimental
Hsp90 data sets to determine the network distance (i.e.,
0, 1, 2, etc., interactions away) between Hsp90 itself and
each Hsp90 target. The average distance to Hsp90 of
Hsp90 targets in both the 30C and 37C data sets was
smaller than expected by chance (see Experimental Pro-
cedures; Figure S3B). This analysis further strengthens
the conclusion that our experimental data sets identified
cellular targets of Hsp90.
The overall interactive character of our Hsp90 network
was further evaluated by statistically analyzing the occur-
rence of major nodes of interaction, or hubs, defined as
proteins with more than 25 interaction partners. Using
this criterion, approximately 20% of all yeast ORFs func-
tion as hubs. Hsp90 targets contained higher than ex-
pected numbers of hubs. We observed a 3.2 enrichment
ratio (p value % 1012) for hubs in the 30C data set. At
37C this enrichment was less pronounced, albeit signifi-
cant (enrichment ratio 2.5; p value% 1012). These results
emphasize the highly interactive nature of Hsp90 targets.
The enrichment of hubs at 30Cmay correlate with our ob-
servation that the 30Cdata set is enriched in components
of multiprotein complexes. The connectivity of Hsp90 tar-
gets was further exploited by extracting from the global
Hsp90 network subnetworks of genes assigned to spe-
cific GO categories (protein folding, stress response, cell
cycle, signal transduction, and protein modification; Fig-
ures 3B–3F). Interestingly, the protein modification sub-network (Figure 3F) contains not only expected Hsp90-
dependent targets such as kinases (i.e., YCK1, YCK3,
CKA1, CKA2), but also the ER-associated IRE1 andCUE1,
members of the ERAD/UPR pathways, suggesting a link
between Hsp90 and ER quality control. This subnetwork
also includes ubiquitin-dependent protein trafficking
components, as well as nearly all subunits of the multive-
sicular body sorting pathway ESCRT I, II, and III com-
plexes. Of note, another ESCRT III complex member,
DID4, ranked numerically at 213 in the 37C data, just out-
side the cutoff for the 206 ORFs comprising the data set
for analysis.
In summary, our network analysis reveals that Hsp90
does not interact with a random set of genes and its func-
tion is not required for random cellular processes. Rather,
Hsp90 targets tend to lie in similar protein complexes,
functional clusters, or pathways, yielding a modular inter-
action network. Interaction subnetworks extracted from
this graphic analysis further underscore the role of
Hsp90 in specific cellular activities, including cell cycle
regulation and cellular transport pathways.
Experimental Validation of Cell Cycle Progression
and Secretion as Two Major Housekeeping
Functions of Hsp90
Combining the graph-theoretical analysis of our data sets
with GO analysis uncovered the modular nature of the
Hsp90 interaction network (Figure 4A). This graphic anal-
ysis highlights two major functional modules in the net-
work, suggesting a role for Hsp90 in cellular trafficking
and transport, as well as in cell cycle regulation. We next
sought to experimentally validate these putative roles of
Hsp90.
First, we focused on the link between Hsp90 and cell di-
vision. Yeast harboring a mutant allele of Hsp90 (G313S)
as their sole source of Hsp90 function exhibited morpho-
logical abnormalities consistent with defective cell cycle
progression (Figure 4Bi, compare WT HSP82 to hsp82
G313S). The cell cycle defect of Hsp90-impaired cells
was also apparent when WT and G313S yeast were syn-
chronized and analyzed by flow cytometry. While yeast
containing WT Hsp90 have clear G1 and G2 populations,
G313S yeast have no defined G1 peak and appear to be
largely arrested as 2N cells (Figure 4Bii, FACS). Consistent
with these results, fluorescence microscopy indicated
that, in contrast to WT cells, G313S cells had an aberrant
morphology, often with both nuclei in only one of the two
cells, or with unequally distributed DNA (Figure 4Bii,
hsp82 G313S inset, arrow and asterisk, respectively).Figure 3. Hsp90 Interaction Network and Associated Cellular Processes
(A) Interaction network generated from curated protein-protein and genetic interactions (see Experimental Procedures) within the 30C and 37Cdata
sets. Blue nodes represent deletion strains in the 30C data set, red nodes represent genes in the 37C data set, and purple nodes indicate genes in
both the 30C and 37C data sets. Blue edges connect blue nodes to blue or purple nodes, red edges connect red nodes to red or purple nodes,
purple edges connect purple nodes, and green edges connect red nodes to blue nodes. Highly interactive experimental nodes or hubs (defined
asR25 interactions within the network) are enlarged and labeled in white.
(B–F) Subnetworks of prevalent GO processes contained within the Hsp90 interaction network: protein folding (B), stress response (C), cell cycle (D),
signal transduction (E), and protein modification (F). Nodes assigned to each GO process are enlarged and labeled with enlarged font. Shown are all
possible shortest-distance paths within the subnetwork between assigned nodes, as well how each subnetwork links back to Hsp90 (HSP82).Cell 131, 121–135, October 5, 2007 ª2007 Elsevier Inc. 127
Figure 4. Biological Validation of Roles
for Hsp90 in the Cell Cycle and in Cellular
Transport
(A) The two main functional modules of the
Hsp90 interaction network, cell cycle and pro-
tein transport, are highlighted.
(B) (Bi) Unsynchronized WT (HSP82) and mu-
tant (hsp82 G313S) yeast were morphologi-
cally examined with bright-field microscopy
(1003). (Bii) WT (HSP82) and mutant (hsp82
G313S) yeast were synchronized with hydroxy-
urea and subsequently fixed and stained with
propidium iodide for analysis by flow cytometry
(FACS) and microscopy (propidium iodide;
1003). Arrow indicates dividing yeast with
both nuclei remaining in mother cell. Asterisk
highlights an example of unequal DNA division.
(C) (Ci) WT or sti1D yeast were grown under
low-glucose conditions in the absence or pres-
ence ofMII and analyzed for secreted invertase
activity with an in-gel assay. pmr1D yeast were
included as a control for defective invertase
glycosylation. The migratory positions of fully
glycosylated and underglycosylated invertase
are indicated. (Cii) Yeast deleted for VPS27
(Dvps27) or the isogenic wild-type strain (WT),
as well as yeast with a mutant Hsp90 allele
(hsp82 E381K) or the parental allele (HSP82)
were transformed with a GFP-Carboxypepti-
dase-S (GFP-CPS) expression plasmid and
analyzed by fluorescence microscopy.Our bioinformatic analysis also suggested a role for
Hsp90 in vesicular transport. To test this prediction, we
employed a general assay for protein secretion. Growing
yeast in low glucose induces a secreted form of the en-
zyme invertase that acquires oligosaccharide modifica-
tions as it transits through the ER and Golgi apparatus
(Figure 4Ci). MII treatment of either WT or sti1D cells dra-
matically reduced the amount of active invertase secreted
to the media (Figure 4Ci). Of note, Hsp90 impairment did
not have an observable effect on the glycosylation state
of either the secreted (Figure 4Ci) or the intracellular
(data not shown) invertase, unlike the loss of glycosylation
observed in pmr1D cells lacking a Golgi-localized manga-
nese pump (Luk and Culotta, 2001). This finding supports
the notion that Hsp90 is required for proper secretory
pathway function.128 Cell 131, 121–135, October 5, 2007 ª2007 Elsevier Inc.Network and GO analysis of our data sets also linked
Hsp90 to several complexes involved in protein vacuolar
targeting, including VPS27, which encodes a cysteine-
rich protein (Piper et al., 1995), and BSD2, an ER mem-
brane protein involved in metal homeostasis (Liu and
Culotta, 1994). Several components of the ESCRT I, II
and III complexes, which participate in the multivesicular
body pathway (Katzmann et al., 2003), were also pres-
ent in our data sets (Table S7; Figure 6B). These bioin-
formatic analyses prompted us to test experimentally if
indeed Hsp90 function is required for proper trafficking
to the vacuole. To this end, we examined the subcellular
localization of GFP fused to Carboxypeptidase S (CPS)
(Katzmann et al., 2003). When sorting of CPS into the
lumen of the vacuole is compromised, as in vps27D de-
letion strains, CPS mislocalizes to the outer, limiting
Figure 5. Overall Properties of the 30C and 37C Hsp90 Targets in the Heterozygous Deletion Collection
(A) Each deletion strain (deleted ORF) was plotted versus the averaged ratio values (Rv) from three independent 30C and 37C experiments. The top
5% of strains exhibiting a growth defect at 30C (average Rv% 0.74395; 273 ORFs) or 37C (average Rv% 0.74946; 281 ORFs) were selected as the
data sets for further study.
(B) Degree of overlap between the top 5% data sets from heterozygous deletion pool 30C and 37C experiments.
(C) Comparison of GO Slim compartment, function, and process categories that are similarly significantly enriched in both the 30C (blue bars) and
37C (red bars) data sets. All assignments shown have (1) a valueR0.7 and%1.3 upon dividing 30C enrichment by 37C enrichment and (2) more
than one ORF assigned to at least one of the two data sets.
(D) Comparison of GO Slim compartment, function, and process categories that exhibit a distinct enrichment change comparing the 30C (blue bars)
and 37C (red bars) data sets. Selection criteria mirror those described in (C), but for values <0.7 or >1.3.membrane of the vacuole and accumulates in aberrant
endosome-like structures (Hettema et al., 2004; Katz-
mann et al., 2003; Odorizzi et al., 2003) (Figure 4Cii).
While GFP-CPS localized correctly to the lumen of the
vacuole in cells containing a WT Hsp90 allele, cells har-
boring the E381K mutant allele of Hsp90 (Nathan et al.,
1997) exhibited a sorting defect similar to that of yeast
lacking VPS27 (Figure 4Cii). Thus, Hsp90 function is in-
deed required for proper trafficking of proteins into the
vacuole.
The agreement between these experiments and the
conclusions of our bioinformatic analysis of the whole-ge-
nome screens validates the basic premise of this study,
namely that the integration of genomic, computational,
and network analyses may constitute a powerful tool to
uncover the underlying logic of the chaperone machinery.In particular, we uncover that Hsp90 is required for both
cell cycle progression and cytokinesis and for proper
function of the secretory pathway.
Comprehensive Network Analysis of Hsp90
in the Secretory Pathway
The global analysis of Hsp90 function using the homozy-
gous diploid deletion collection necessarily overlooks es-
sential genes. To better define Hsp90 involvement in pro-
tein secretion, we extended our analysis by performing
a similar screen on the heterozygous diploid deletion col-
lection, which contains barcode-tagged deletions in one
allele of both essential and nonessential genes.
The experimental strategy for the screen and analysis of
the resulting data sets was essentially as described for the
homozygous deletion screen (Figure 5A, 30C, 37C;Cell 131, 121–135, October 5, 2007 ª2007 Elsevier Inc. 129
Table S8). The resulting 30C heterozygous top 5% data
set consists of 273 ORFs, all with an average Rv
%0.744, and the 37C data set contains 281 ORFs with
an average Rv%0.749. As observed for the homozygous
screen, the 30C and 37C data sets exhibited only partial
overlap (40 ORFs; Figure 5B).
Analysis of the data sets using available GO Slim classi-
fications (Table S9; Figure 5CD) revealed that, as ob-
served for the homozygous deletion screen, some cellular
functions were significantly enriched among Hsp90 tar-
gets at both temperatures (Figure 5C), while there were
also noteworthy differences between the data sets ob-
tained at different temperatures (Figure 5D). In contrast
to what we observed in the homozygous deletion screen,
both the 30C and 37C heterozygous data sets were sim-
ilarly enriched in ORFs involved in cellular transport (i.e.,
vesicle-mediated transport, Golgi apparatus, endoplas-
mic reticulum, vacuole; Figure 5D). These may reflect the
enhanced dependence of essential genes on Hsp90 or
may result from the different nature of this screen, which
examines sensitivity to Hsp90 under conditions where at
least half of the gene dosage is available. Importantly,
screening the heterozygous deletion collection confirmed
our previous findings that Hsp90 inhibition has wide-
spread effects on the secretory pathway.
Taking advantage of our extensive data set of essential
and nonessential targets of Hsp90, we next constructed
a comprehensive map of Hsp90-secretory pathway inter-
actions (Figure 6A). Graph-theoretical analysis combined
all curated physical and genetic interactions with the
genes in our homozygous and heterozygous data sets
corresponding to the GO biological process classifica-
tions for either ‘‘secretory pathway’’ or ‘‘vesicle-mediated
transport,’’ or the GO subcellular compartment classifica-
tion for ‘‘endoplasmic reticulum.’’ The resulting Hsp90-se-
cretory pathway interaction network contains 113 ORFs
and 417 interactions. This network analysis underscored
our previous observation that Hsp90 functions in virtually
every aspect of the exocytic andendocytic secretory path-
way. Many defined complexes, processes, and types of
enzymes were identified as Hsp90 targets (Tables S7
and S9). Prominent among the targets were multisubunit
complexes, including ESCRT I, II, and III; AP-adaptor com-
plexes; and components of the vesicle-tethering COG and
TRAPP complexes (Table S7 and Figures 6A, 6B, and 6D).
Another noteworthy class of targets were transport-
related GTPases, including the Rab-like VPS21, YPT6,
YPT7, YPT32, ARL1, ARL3, ARF1, and SEC4, consistent
with previous studies indicating that Hsp90 is required
for Rab1 and Rab3a recycling in mammalian cells (Saki-
saka et al., 2002; Chen and Balch, 2006). Notably, while
these previous studies identified GDI as an additional tar-
get of Hsp90, we only observed the essentialGDI1 gene in
positions 2932/5467 and 1998/5576 in the heterozygous
30C and 37C ranked data, respectively (Table S8). It is
likely that the heterozygous screen is insensitive to impair-
ment of genes, such asGDI, that act catalytically, and thus
may be less affected by gene dosage. Another interesting130 Cell 131, 121–135, October 5, 2007 ª2007 Elsevier Inc.class of Hsp90 targets comprised components of the UPR
and ERAD pathways, including the kinase IRE1 and its
effector HAC1, as well as HRD1, CUE1, and various ER
Hsp40-type cochaperones such as ERJ5, JEM1, SCJ1,
and HLJ1. These latter findings link ER folding and quality
control, as well as the sensing of ER stress, to the cyto-
solic Hsp90 chaperone machinery.
The surprising diversity of Hsp90 targets within the se-
cretory pathway raises the possibility that Hsp90 exerts
its action on different aspects of this pathway through di-
rect interaction with multiple proteins and complexes. Al-
ternatively, Hsp90 could act by interacting with a single
family of effectors, such as Rabs, with pleiotropic activi-
ties. To distinguish between these possibilities, we used
curated protein interaction maps obtained by proteomic
analysis of S. cerevisiae complexes to determine the
range of physical interactions between the secretory path-
way Hsp90 targets from our screen and the Hsp90 chap-
erone machinery (Figure 6B). This network analysis re-
vealed that Hsp90 and its chaperone cofactors interact
directly with a wide spectrum of Hsp90 targets with differ-
ent structural and functional properties, including Cog6p,
Vps28p, Hrd1p, Apl2p, and Erg1p, as well as several Rab
proteins (Figure 6B). This analysis supports the idea that
Hsp90exerts its function throughdirect physical interaction
with many different components of the secretory pathway.
Notably, the subunits of several multiprotein complexes
involved in vesicle tethering (COG and TRAPP complexes)
or endosome/vacuole transport (ESCRT I, II, and III com-
plexes) were present in theHsp90 physical interaction net-
work (highlighted in Figure 6B). Because many of these
complexes are highly dynamic and undergo highly regu-
lated assembly/disassembly cycles during vesicle traffick-
ing, it is tempting to speculate that Hsp90 may mediate
their assembly or modulate their conformational cycle.
The Hsp90 physical interaction network was surpris-
ingly sparse, suggesting that existing global proteomic
analyses only detect a small subset of cellular physical in-
teractions. We next used the COG complex to test this
possibility. The COG complex is composed of two sub-
complexes, lobe A and lobe B (Figure 6C; Ungar et al.,
2002). Intriguingly, all the COG subunits in lobe B were
found in our screen (Table S7). In contrast, only Cog6p
contacted Hsp90 in the physical interaction network
based on published proteomic studies (Figure 6B). We
thus examined whether Hsp90 also interacts with the re-
maining three lobe B COG subunits (Figure 6C). Affinity
isolation of GST-tagged COG subunits followed by immu-
noblot analysis for Hsp90 demonstrated that Hsp90 phys-
ically interacts with COG complex lobe B subunits Cog5p,
Cog7p, and Cog8p (Figure 6B). The observation that all
lobe B subunits revealed in our screen interact with
Hsp90 suggests that this chaperone may participate in in-
tralobe B or interlobe COG complex assembly. Further-
more, our analysis indicates that amore thorough physical
interaction analysis, geared to stabilize labile Hsp90 inter-
actions, will be required to elucidate the full range of cellu-
lar Hsp90 substrates.
Figure 6. Whole-Genome Analysis of Secretory Pathway Genes Affected by Hsp90 Inhibition
(A) Hsp90-secretory pathway interaction network generated from curated protein-protein and genetic interactions related to the secretory pathway
(see Results for details) within the homozygous and heterozygous 30C and 37C data sets. For labeling details, refer to Figure 3A legend.
(B) Physical Hsp90-secretory pathway network. Only curated physical interactions are included. Hsp90 (HSC82 and HSP82 in enlarged yellow nodes)
and well-established Hsp90 cochaperones are connected by gray edges. For other labeling details, refer to the legend for Figure 3A. Transport-re-
lated complexes are highlighted with overlays: blue, COG complex; yellow, TRAPP complex; green, retromer complex; purple, ESCRT I, II, and III
complexes; orange, AP-1 and AP-3 adaptor complexes.
(C) Hsp90 physically interacts with all subunits of lobe B in the COG complex. (Ci) Scheme of the bilobular COG complex. (Cii and Ciii) Glutathione-
affinity isolation of complexes from yeast expressing GST or GST-COG5, -7, or -8 fusion proteins, separated by SDS-PAGE and stained with Coo-
massie blue (Cii). (Ciii) Total extracts (10 mg each lane) or affinity-isolated proteins were transferred to nitrocellulose, and Hsp90 was detected with
anti-Hsp90 polyclonal antisera.
(D) Schematic representation of points of action of Hsp90 in the secretory pathway from our analysis.DISCUSSION
Multiple Cellular Functions of Hsp90
Our analysis revealed differences in the cellular processes
sensitive to Hsp90 impairment at normal and elevated
growth temperatures, indicating that the essential func-
tions of Hsp90 change according to the needs of the
cell. For example, while vesicle-mediated transport was
significantly enriched in both 30C and 37C data sets,
Hsp90 inhibition affected this process more profoundly
under normal growth conditions (Figure 2C). At elevated
temperatures, however, Hsp90 inhibition proved more
detrimental for ORFs important for the G1 phase of thecell cycle, signal transduction, and cytokinesis (Table S3
and Figure 2C). Interestingly, Hsp90 has previously been
linked to kinetochore assembly in yeast (Bansal et al.,
2004; Lingelbach and Kaplan, 2004; Stemmann et al.,
2002). Most components involved in kinetochore assem-
bly are essential for viability and thus not present in the ho-
mozygous deletion collection. However, our heterozygous
deletion collection screen revealed several essential kinet-
ochore components as extremely sensitive to Hsp90 inhi-
bition (SKP1 and CTF13 rank in the top 5% at both 30C
and 37C; SGT1 is in the top 5% at 30C). Consistent
with these findings, SGT1 has been reported to physically
link Hsp90 to SKP1 (Catlett and Kaplan, 2006). Further,Cell 131, 121–135, October 5, 2007 ª2007 Elsevier Inc. 131
a protein kinase involved in kinetochore function, MCK1,
ranks in the top 5.1% at 37C and top 6.2% at 30C (of
MII-sensitive homozygous deletion strains; Table S1),
barely missing inclusion in our stringent top 5% data sets.
MCK1 heterozygous deletion yeast were in the top 5% at
37C (Table S8). Our conclusion that Hsp90 is required for
cell cycle progression at elevated temperatures is consis-
tent with data from mammalian cells demonstrating that
Hsp90 function is necessary for mitosis (de Carcer,
2004; Fortugno et al., 2003; Lange et al., 2002; Nomura
et al., 2004).
The good agreement between genomic, cell biological,
and bioinformatic data suggests that our data sets repre-
sent bona fide cellular targets of Hsp90. While the use of
any chemical inhibitor can theoretically cause toxicity un-
related to the inhibition of the target of that inhibitor, the
ansamycin antibiotics, of which MII is a member, are ex-
quisitely specific for Hsp90 and thus unlikely to have
unwanted secondary effects. Furthermore, comparing
our data sets with previous studies that identified Hsp90
interactors, including multipronged genetic and biochem-
ical approaches (Zhaoet al., 2005) and those aimedspecif-
ically at physical interactions (Millson et al., 2005), showed
that our data sets were statistically significantly enriched,
especially for genetically established interactors (p value
1 3 1012; Table 1). Altogether our analysis suggests that
Hsp90 function is important for vesicular transport under
normal growth temperatures. Hsp90 is also required for
continued cell division, particularly at stress-inducing tem-
peratures. Additionally, Hsp90 appears to fulfill general
housekeeping roles in the day-to-day activities of the
cell, as several important cellular processes were equally
represented at 30Cand37C, such as transcription factor
activity or mitochondrial function. Given the high level of
chaperone conservation between yeast and humans,
together with the observation that human Hsp90 can sup-
plant yeast Hsp90 in vivo (Picard et al., 1990), our conclu-
sions may also apply to Hsp90 action in higher organisms.
Role of Hsp90 in Vesicular Transport
and Protein Secretion
Hsp90 targets include components of virtually every as-
pect of the exocytic and endocytic secretory pathway.
Our targets include several small GTPases, including nu-
merous Rab-like proteins (Table S7), consistent with pre-
vious reports that Hsp90 functions in Rab-GTPase recy-
cling (Sakisaka et al., 2002; Chen and Balch, 2006). In
addition, Hsp90 also interacts physically and genetically
with several structurally and functionally unrelated pro-
teins, including subunits of tethering complexes as well
as coat complexes and adaptor complexes (Figure 6D;
Table S7). Of note, the role of Hsp90 in GTPase function
is not restricted to the secretory pathway, as Hsp90 tar-
gets also included several other GTPases, including
FUN12, RAS2, RHO1, and RHO3.
The identification of Hsp90 as central to secretory path-
way function has several important implications. First,
linking a cytosolic stress-regulated chaperone with vesic-132 Cell 131, 121–135, October 5, 2007 ª2007 Elsevier Inc.ular transport could provide a mechanism to attenuate
protein secretion during stress. Second, it could provide
a new rationale for the anticancer activity of Hsp90 inhib-
itors. Understanding the basis for the increased sensitivity
of tumor cells to Hsp90 inhibition has proven elusive
(Chiosis and Neckers, 2006). Because proliferation is crit-
ically dependent on membrane trafficking, even a mild im-
pairment of this process would inhibit cell growth. Of note,
many oncogenic processes require recycling via the
ESCRT pathway (Ryan et al., 2006; Thompson et al.,
2005), which, as shown here (Figure 4Cii), depends on
Hsp90 function. Intriguingly, the combination of Hsp90
and proteasome inhibitors has a synergistic cytotoxic ef-
fect leading to severe disruption of the ER, consistent
with a role of Hsp90 in the secretory pathway (Mimnaugh
et al., 2006). Thus, a better understanding of Hsp90 func-
tion in the secretory pathway in the context of tumorigen-
esis could lead to the design of more potent and effective
combinatory therapies (Chen and Balch, 2006).
Chaperone Function of Hsp90
How does Hsp90 function in these diverse processes?
The current understanding of Hsp90 function in tyrosine
kinase and steroid hormone receptor maturation suggests
that Hsp90 binds to ‘‘clients’’ that are substantially folded
and facilitates their conformational remodeling (Figure 7;
Pearl and Prodromou, 2006; Vaughan et al., 2006). This
view of Hsp90 as a chaperone that stabilizes or remodels
proteins that already possess substantial native charac-
teristics would be consistent with our observations. For
Figure 7. Models of Hsp90 Function In Vivo
For Hsp90 ‘‘clients,’’ protein synthesis and early folding events yield
a metastable state that interacts with Hsp90. The Hsp90 chaperone
network may act to stabilize the labile conformations of proteins that
only become fully folded upon binding to a ligand (orange ring), or par-
ticipate in assembly and disassembly of multiprotein complexes (ring
of circular subunits); Hsp90 may also function to stabilize labile protein
conformations generated during conditions of cellular stress (green
circle).
instance, many aspects of vesicular transport and protein
trafficking involve the ordered assembly and disassembly
of large multisubunit complexes (Figure 7). The enrich-
ment in complex-forming proteins in our 30C data set
prompts us to speculate that Hsp90 stabilizes subunits
of these complexes prior to assembly or facilitates their
conformational transitions during either binding or re-
moval of these large hydrophobic complexes from mem-
branes. Similarly, many components of the microtubule
organizing center and kinetochores undergo ordered as-
sembly and disassembly processes. During stress, e.g.,
at elevated temperatures, Hsp90 likely stabilizes labile
conformations of many proteins, most notably cell cycle
components (Figure 7).
In addition to Hsp90, other chaperone systems function
in the eukaryotic cytosol (Frydman, 2001; Young et al.,
2004). For example, the TRiC/CCT and GimC/Prefoldin
chaperones interact with newly synthesized proteins and
assist their folding to the native state. While Hsp90 is be-
lieved to act downstream of initial folding attempts, our
data sets reveal an interaction of Hsp90 with two subunits
of GimC, GIM4 and PFD1. Genetic interactions between
Hsp90 and another subunit, GIM3, have been reported
(Tong et al., 2004). Further, many sensitive deletion strains
uncovered in our screen exhibit interactions with GIM4 in
our network analysis (Figure 3AB). These results suggest
a link between the GimC/Prefoldin chaperone and
Hsp90. Further studies should clarify the interplay be-
tween these chaperone systems. For instance, they could
carry out partially redundant functions. Alternatively, loss
of GimC could impair folding of some newly made pro-
teins, rendering them hyperdependent on the posttransla-
tional assistance of Hsp90. We also find several links be-
tween Hsp90 and ER folding and quality control
components. In principle this could reflect the cooperation
between the cytosolic chaperone machinery and ER
chaperones in the folding and maturation of transmem-
brane proteins with both cytosolic and lumenal domains,
as shown recently for CFTR (Wang et al., 2006), as well
as the role of cytosolic chaperones in the degradation of
retrotranslocated ERAD substrates (Meusser et al., 2005).
In sum, our combined systems approach identified
novel Hsp90-dependent processes andmay open theway
to uncover novel functions for the numerous other compo-
nents of the folding and quality control machineries.
EXPERIMENTAL PROCEDURES
Growth of Yeast Deletion Collections
Homozygous diploid deletion strains in the BY4743 background
(Brachmann et al., 1998) were used in all experiments. The systematic
construction of the deletion strains and the deletion pools have been
previously described (Giaever et al., 1999, 2002). Pooled homozygous
deletion strains were grown for ten generations in the absence (DMSO;
no drug control) or presence of MII (200 mM and 400 mM; macbecin II
courtesy of the National Cancer Institute), and equivalent numbers of
cells were sampled and frozen at80C. Genomic DNA was prepared
from these samples, and the deletion strain-specific molecular barco-
des were amplified by PCR. For details of growth, genomic DNA isola-tion, primer sequences, and PCR conditions, see the Supplemental
Data.
Array Hybridization and Preliminary Analysis
Amplified UPTAG and DOWNTAG sequences were combined and
used to probe high-density oligonucleotide arrays containing probes
complementary to the yeast deletion tags (Tag3 arrays, Affymetrix,
Santa Clara) as previously described (Giaever et al., 1999, 2002). For
details, see the Supplemental Data. Processed arrays were visualized
with an Affymetrix scanner, and the intensity of each element on the ar-
ray was calculated (CEL file). Affymetrix CEL files were then imported
into a custom Matlab (Mathworks) software package for analysis and
the Rv computed as described in the Supplemental Data. The ranked
deletion strains were then plotted versus their average Rv. The early
linear phase of the graph represents the strains most negatively af-
fected by Hsp90 inhibition, and a cutoff was drawn accordingly consti-
tuting the top 5% of sensitive deletion strains.
Broad Characterization of Hsp90 Targets Using
GO and GO Slim Assignments
The GO database (Harris et al., 2004) was utilized to collect a list of GO
categories. In these classifications, gene products can be affiliated
with one or more GO category assignments. These assignations
were first used to look for enriched cellular components, functions,
and processes in our experimental Hsp90 target data sets (see Table
S4). We then determined the molecular function, biological process,
and cellular component for each yeast protein according to its GO
Slim annotations (Harris et al., 2004; Dwight et al., 2004). For details,
see the Supplemental Data.
Yeast Interaction Network and Hsp90 Target Subnetwork
Yeast physical and genetic interactions are taken from the BioGRID
database (Stark et al., 2006). From these interactions, we established
a list of known Hsp90 interactors, defined as the core Hsp90 interac-
tome of cofactors (HSP82, HSC82, CNS1, CPR6, CPR7, STI1,
SBA1, AHA1, HCH1, CDC37), as well as the interaction partners for
each of these genes. The resulting ‘‘known’’ Hsp90 interactors com-
prise 750 genes, 468 of which are known to be nonessential. Among
these nonessential genes, 415 were tested at 30C, and 458 were
tested at 37C.
Visualization and Analysis of the Hsp90 Target Subnetwork
The experimental network was visualized using Pajek (Batagelj and
Mrvar, 1998). Several statistical and graph-theoretic analyses were
performed for Hsp90 targets in relation to the yeast interaction network
as described in the Supplemental Data.
Determining Enriched Features in Hsp90 Targets
Pfam, a database for protein domain and family classification (Bate-
man et al., 2004), was used to determine what types of proteins
most commonly occurred in our data sets. Complex formers were de-
fined using the MIPS (Mewes et al., 2004) complex catalog. For this
analysis, an interaction between two proteins was assumed if the pro-
teins belonged to the same complex. A complex former was then de-
fined as a protein having more than one established interaction part-
ner. The statistical analysis used to determine whether a particular
protein feature is enriched in Hsp90 targets is described in detail in
the Supplemental Data.
GST Pulldown Experiments
Yeast expressing GST alone or GST-COG5, -7, or -8 fusion proteins
(courtesy of Michael Snyder; the GST-COG6 construct from this re-
source does not express a protein of the correct size andwas therefore
excluded from this analysis) were lysed in GST buffer (25 mM Tris [pH
8.0], 150 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 2.5% glycerol, 1 mM
DTT, 0.1% Triton X-100, and protease inhibitors), and pulldowns con-
taining 25 ml of GST-Sepharose (Amersham Pharmacia Biotech,Cell 131, 121–135, October 5, 2007 ª2007 Elsevier Inc. 133
Piscataway, NJ) slurry and 2 mg of protein in a total volume of 350 ml
were rotated at 4C for 20 min. Isolated proteins were resolved on
12%SDS-PAGE gels and either Coomassie blue stained or transferred
to nitrocellulose and probed with anti-Hsp90 antisera (kind gift of
Avrom Caplan).
Fluorescence Microscopy
Yeast transformed with a CPS-GFP construct (courtesy of Scott Emr)
were grown overnight at 30C to mid-log phase (OD600 = 0.5–0.8).
Conventional GFP fluorescence micrographs were obtained using
a Zeiss Axiovert 200M microscope. For details, see the Supplemental
Data.
Invertase Activity Assay
This experiment was performed essentially as previously described
(Luk and Culotta, 2001; Poon et al., 1999). For details, see the Supple-
mental Data.
Cell Cycle Synchronization and Flow Cytometry
Yeast were synchronized in 150 mM hydroxyurea for 3.5 hr., released
for 2 hr, and subjected to FACS analysis on an FHCRC Becton Dickin-
sonmachine. Samples of the same cells were analyzed bymicroscopy
to observe propidium iodide-labeled DNA. For experimental details
see the Supplemental Data.
Supplemental Data
The Supplemental Data include Supplemental Experimental Proce-
dures, three figures, and nine tables and can be found with this article
online at http://www.cell.com/cgi/content/full/131/1/121/DC1/.
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